Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ALKS, ALKSV | Alkermes plc. | EVP R&D, Chief Medical Officer | $6.23 M | Feb 23, 2024 | ||
ALBO | ALBIREO PHARMA, INC. | Director | $460 K | Mar 2, 2023 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|